Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Depreciation and Depletion (2024 - 2025)

Medifast (MED) has disclosed Depreciation and Depletion for 2 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion rose 13.04% year-over-year to $2.6 million, compared with a TTM value of $10.5 million through Dec 2025, down 39.66%, and an annual FY2025 reading of $10.5 million, down 39.66% over the prior year.
  • Depreciation and Depletion was $2.6 million for Q4 2025 at Medifast, up from $2.5 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $10.5 million in Q2 2024 and bottomed at $2.3 million in Q1 2024.